NCT00225199View on ClinicalTrials.gov

Efficacy and Safety of SH T00660AA in Treatment of Endometriosis

PHASE3CompletedINTERVENTIONAL
Enrollment

198

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

September 30, 2006

Conditions
Endometriosis
Interventions
DRUG

Visanne (BAY86-5258, SH T00660AA)

orally once daily

DRUG

Placebo

orally once daily

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY